Karin would have a better handle on the exact timeline but lets start here:
December 1, 2009 – Stem Cell Therapy International Inc. (OTCBB: SCII) announced that it has signed an agreement with Histostem Ltd. of South Korea (“Histostem”), for the exclusive, worldwide rights to the distribution of the Company’s existing SteMixx line of stem cell based cosmetic products, as well as future products under development. Previously available for purchase only in Korea, SteMixx received approval last month from the Korean FDA as an effective cosmetic for the treatment of aging skin. Stem Cell Therapy International will seek similar product validations from regulatory agencies in the United States and Europe and expects to begin distributing SteMixx products in the United States in early 2010.
DISTRUBUTION early 2010! Almost a year behind schedule and counting.